Among the tested genetic variants, rs75508464 variant near CELA3B (chymotrypsin-like elastase 3B) gene seems to document a significant effect on NASH resolution in patients receiving OCA [133]. The gene discussed is CELA3B; the disease is metabolic dysfunction-associated steatohepatitis.